Imperus Announces Restatement of MD&A and Update

TORONTO, ONTARIO--(Marketwired - March 26, 2015) - Imperus Technologies Corp. ("Imperus" or the "Company") (TSX VENTURE:LAB)(FRANKFURT:ISX)(FRANKFURT WKN: A12B58) announces that in connection with the closing of its previously announced private placement financing of 70,644,500 subscription receipts of the Company at a price of $0.35 per subscription receipt (the "Offering"), it will file a final prospectus to qualify the distribution of the common shares and warrants issuable on the automatic exercise of the subscription receipts (the "Prospectus"). The Prospectus will incorporate by reference the unaudited financial statements and management's discussion and analysis of the Company for the interim period ended September 30, 2014 with comparative figures to the same period ended September 30, 2013. The figures in the management's discussion and analysis for the interim period ended September 30, 2014 have been restated to reflect certain changes. For details of the impact to the results of the Company, please refer to the detailed disclosure included in the amended and restated management's discussion and analysis for the interim period ended September 30, 2014, which is available on SEDAR at www.sedar.com.

The substance of the changes is as follows:

• The Company enhanced the description of the changes made to the restated unaudited interim financial statements dated September 30, 2014;
• The Company included disclosure of the Casina platform in accordance with item 1.4(d) of Form 51-102F1;
• The Company included a discussion of "software and royalties" and a discussion of the year to date interest income;
• The Company included a discussion on the impact of the acquisitions of Vast Studios Inc. and Diwip Ltd. on liquidity and capital resources;
• The Company added updated information regarding the Offering and Diwip acquisition in discussing subsequent events; and
• The Company included a discussion on the results on the nine months ended September 30, 2014.

First Supplement to Subscription Receipt Agreement